Multiple neuropeptide Y receptors are involved in cardiovascular regulation. Peripheral and central mechanisms
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ali-Rachedi, 1984, Peptide YY (PYY) immunoreactivity is co-stored with glucagon-related immunoreactants in endocrine cells of the gut and pancreas, Histochemistry, 80, 487, 10.1007/BF00495439
Anderson, 1990, Distribution and relative abundance of neurons in the pigeon forebrain containing somatostatin, neuropeptide Y, or both, J. comp. Neurol., 299, 261, 10.1002/cne.902990302
Arzubiaga, 1991, Neuropeptide Y, a putative cotransmitter in noradrenergic neurons, induces mast cell degranulation but not prostaglandin D2 release, J. Allergy clin. Immun., 87, 88, 10.1016/0091-6749(91)90216-B
Aubert, 1988, Effects of neuropeptide Y on the blood pressure response to various vasoconstrictor agonists, J. Pharmac. exp. Ther., 246, 1088
Balasubramaniam, 1990, Characterization of neuropeptide Y binding sites in rat cardiac ventricular membranes, Peptides, 11, 545, 10.1016/0196-9781(90)90057-C
Böttcher, 1984, Co-existence of peptide YY and glicentin immunoreactivity in endocrine cells of the gut, Regul. Pept., 8, 261, 10.1016/0167-0115(84)90034-X
Böttcher, 1986, Co-existence of glicentin and peptide YY in colorectal L-cells in cat and man, Regul. Pept., 13, 283, 10.1016/0167-0115(86)90046-7
Brown, 1989, Neuropeptide Y: Biological and clinical studies, 201
Carter, 1985, Cardiovascular effects of neuropeptide Y in the nucleus tractus solitarius of rats: Relationship with noradrenaline and vasopressin, Peptides, 6, 421, 10.1016/0196-9781(85)90107-X
Castagné, 1987, Stress-induced changes of circulating neuropeptide Y in the rat: comparison with catecholamines, Regul. Pept., 19, 55, 10.1016/0167-0115(87)90074-7
Castan, 1992, Identification and functional studies of a specific peptide YY-preferring receptor in dog adipocytes, Endocrinology, 131, 1970, 10.1210/en.131.4.1970
Cervin, 1992, Neuropeptide Y 16–36 inhibits mucociliary activity but does not affect blood flow in the rabbit maxillary sinus in vivo, Regul. Peptides, 39, 237, 10.1016/0167-0115(92)90544-5
Chang, 1986, Increased neuropeptide Y (NPY) receptor binding in hippocampus and cortex of spontaneously hypertensive (SH) rats compared to normotensive WKY rats, Neurosci. Lett., 67, 275, 10.1016/0304-3940(86)90321-6
Ciriello, 1986, Function of the ventrolateral medulla in the control of the circulation, Brain Res., 11, 359, 10.1016/0165-0173(86)90005-6
Colmers, 1991, Presynaptic inhibition by neuropeptide Y in rat hippocampal slice in vitro is mediated by a Y2 receptor, Br. J. Pharmac., 102, 41, 10.1111/j.1476-5381.1991.tb12129.x
Cox, 1990, The effects of neuropeptide Y and its fragments upon basal and electrically stimulated ion secretion in rat jejunum mucosa, N.Y. Acad. Sci. U.S.A., 611, 399, 10.1111/j.1749-6632.1990.tb48963.x
Dahlöf, 1985, Neuropeptide Y (NPY) reduces field stimulation-evoked release of noradrenaline and enhances force concentration in the rat portal vein, Naunyn Schmiedebergs Archs Pharmac, 328, 327, 10.1007/BF00515562
Dahlöf, 1986, α-Adrenoceptor mediated inhibition of nerve stimulation-evoked release of neuropeptide Y (NPY)-like immunoreactivity in the pithed guinea-pig, Eur. J. Pharmac., 131, 279, 10.1016/0014-2999(86)90583-2
Daly, 1988, The role of neuropeptide Y in vascular sympathetic neurotransmission may be enhanced in hypertension, J. Hypertension, 6, S535, 10.1097/00004872-198812040-00168
Dampney, 1981, Brainstem mechanisms in the control of arterial pressure, Clin. exp. Hypertension, 3, 379, 10.3109/10641968109033672
De Potter, 1988, Evidence for the co-storage and co-release of neuropeptide Y and noradrenaline from large dense cored vesicles in sympathetic nerves of the bovine vas deferens, Synapse, 2, 157, 10.1002/syn.890020207
De Quidt, 1986, Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system. II. Immunohistochemical analysis, Neuroscience, 18, 545, 10.1016/0306-4522(86)90057-6
De Quidt, 1990, Pancreatic polypeptide, neuropeptide Y and peptide YY in central neurons, vol. 9, 287
Edvinsson, 1984, Neuropeptide Y potentiates the effects of various vasoconstrictor agents on rabbit blood vessels, Br. J. Pharmac., 85, 519, 10.1111/j.1476-5381.1984.tb16516.x
Edvinsson, 1987, Effects of neuropeptide Y on the cardiovascular system, Trends Pharmac. Sci., 8, 231, 10.1016/0165-6147(87)90069-1
Edvinsson, 1991, Increased plasma levels of neuropeptide Y-like immunoreactivity and catecholamines in severe hypertension remain after treatment to normotension in man, Regul. Pept., 32, 279, 10.1016/0167-0115(91)90021-8
Ekblad, 1984, Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular fibres, Regul. Pept., 8, 225, 10.1016/0167-0115(84)90064-8
Ekblad, 1984, VIP and PHI coexist with an NPY-like peptide in intramural neurones of the small intestine, Regul. Pept., 10, 47, 10.1016/0167-0115(84)90052-1
Ekblad, 1991, Microanatomy and chemical coding of peptide-containing neurons in the digestive tract, 141
Eva, 1990, Molecular cloning of a novel G-protein-coupled receptor that may belong to the neuropeptide receptor family, FEBS Lett., 271, 81, 10.1016/0014-5793(90)80377-U
Fallgren, 1989, Co-existence of neuropeptides and differential inhibition of vasodilator responses by neuropeptide Y in guinea pig uterine arteries, Neurosci. Lett., 100, 71, 10.1016/0304-3940(89)90662-9
Flood, 1989, Dissociation of the effects of neuropeptide Y in feeding and memory: Evidence for pre- and postsynaptic mediation, Peptides, 10, 963, 10.1016/0196-9781(89)90176-9
Fried, 1985, Subcellular storage and axonal transport of neuropeptide Y (NPY) in relation to catecholamines in the cat, Acta physiol. scand., 125, 145, 10.1111/j.1748-1716.1985.tb07701.x
Fried, 1985, Evidence for differential localization of noradrenaline and neuropeptide Y (NPY) in neuronal storage vesicles isolated from rat vas deferens, J. Neurosci., 5, 450, 10.1523/JNEUROSCI.05-02-00450.1985
Fuhlendorff, 1990, [Leu31, Pro34]Neuropeptide Y—a specific Y1 receptor agonist, 187, 182
Fuxe, 1983, Central administration of neuropeptide Y induces hypotension and bradypnea and EEG synchronization in the rat, Acta physiol. scand., 118, 189, 10.1111/j.1748-1716.1983.tb07261.x
Glover, 1984, Conformal studies of the pancreatic polypeptide hormone family, Eur. J. Biochem., 142, 379, 10.1111/j.1432-1033.1984.tb08298.x
Granata, 1985, Sympathoinhibition by A1-noradrenergic neurones is mediated by neurones in the C1 area of the rostral medulla, J. Auton. Nerv. Syst., 14, 387, 10.1016/0165-1838(85)90084-0
Grundemar, 1991, Neuropeptide Y, peptide YY and C-terminal fragments release histamine from rat peritoneal mast cells, Br. J. Pharmac., 104, 776, 10.1111/j.1476-5381.1991.tb12505.x
Grundemar, 1992, Unmasking the vasoconstrictor response to neuropeptide Y and its interaction with vasodilating agents, Eur. J. Pharmac., 221, 71, 10.1016/0014-2999(92)90773-W
Grundemar, 1990, Effects of various neuropeptide Y/peptide YY fragments on electrically-evoked contractions of the rat vas deferens, Br. J. Pharmac., 100, 190, 10.1111/j.1476-5381.1990.tb12075.x
Grundemar, 1988, Neuropeptide Y: prejunctional inhibition of vagally induced contractions in the guinea pig trachea, Regul. Pept., 23, 309, 10.1016/0167-0115(88)90231-5
Grundemar, 1990, Suppression by neuropeptide Y of capsaicin-sensitive sensory nervemediated contraction in guinea-pig airways, Br. J. Pharmac., 99, 473, 10.1111/j.1476-5381.1990.tb12952.x
Grundemar, 1990, Biphasic blood pressure response to neuropeptide Y in anesthetized rat, Eur. J. Pharmac., 179, 83, 10.1016/0014-2999(90)90404-T
Grundemar, 1991, Long-lasting inhibition of the cardiovascular response to glutamate and the baroreceptor reflex elicited by neuropeptide Y injected into the nucleus tractus solitarius, Neurosci. Lett., 122, 135, 10.1016/0304-3940(91)90211-B
Grundemar, 1991, Neuropeptide Y acts at an atypical receptor to evoke cardiovascular depression and to inhibit glutamate responsiveness in the brain stem, 258, 633
Grundemar, 1992, Characterization of vascular receptors for neuropeptide Y, Br. J. Pharmac., 105, 45, 10.1111/j.1476-5381.1992.tb14208.x
Grundemar, 1993, Activation of neuropeptide Y1 and neuropeptide Y2 receptors by substituted and truncated neuropeptide Y analogs: identification of signal epitopes, Eur. J. Pharmac., 232, 271, 10.1016/0014-2999(93)90784-F
Grundemar, 1993, Characterization of receptor types for neuropeptide Y and related peptides
Grundemar, 1993, Neuropeptide Y suppresses the neurogenic inflammatory response in the rabbit eye; mode of action, Regul. Pept., 243, 64
Guertzenstein, 1974, Fall in blood pressure produced from discrete regions of the ventral surface of the medulla by glycine and lesions, J. Physiol., Lond., 242, 489, 10.1113/jphysiol.1974.sp010719
Haass, 1989, Characterization and presynaptic modulation of stimulation-evoked exocytotic co-release of noradrenaline and neuropeptide Y in guinea pig heart, Naunyn-Schmiedberg's Archs Pharmac., 339, 71, 10.1007/BF00165129
Håkanson, 1986, Neuropeptide Y: Coexistence with noradrenaline. Functional implications, Vol. 68
Han, 1987, Neuropeptide Y potentiates contraction and inhibits relaxation of rabbit coronary arteries, J. cardiovasc. Pharmac., 9, 675, 10.1097/00005344-198706000-00006
Heilig, 1988, Neuropeptide Y (NPY) induced activity suppression in the rat: evidence for NPY receptor heterogeneity and for interaction with alpha-adrenergic receptors, Eur. J. Pharmac., 157, 205, 10.1016/0014-2999(88)90384-6
Herzog, 1992, Cloned human neuropeptide Y receptor couples to different second messenger systems, 89, 5794
Higuchi, 1988, Neuropeptide Y inhibits the acetylcholine-mediated release of catecholamines from bovine adrenal chromaffin cells, J. Pharmac. exp. Ther., 244, 468
Hökfelt, 1983, Occurrence of neuropeptide Y (NPY)-like immunoreactivity in catecholamine neurons in the human medulla oblongata, Neurosci. Lett., 36, 217, 10.1016/0304-3940(83)90003-4
Hökfelt, 1984, Transmitter and peptide systems in areas involved in the control of blood pressure, Clin. exp. Hyper. Theory Practice, A6, 23, 10.3109/10641968409062549
Hulting, 1990, Plasma neuropeptide Y on admission to a coronary care unit; raised levels in patients with left heart failure, Cardiovasc. Res., 24, 102, 10.1093/cvr/24.2.102
Krstenansky, 1989, Centrally truncated and stabilized porcine neuropeptide Y analogs: Design, synthesis, and mouse brain receptor binding, 86, 4377
Krstenansky, 1990, C-terminal modifications of neuropeptide Y and its analogs leading to selectivity of the mouse brain receptor over the porcine spleen receptor, Neuropeptides, 17, 117, 10.1016/0143-4179(90)90073-8
Larhammar, 1992, Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type, J. biol. Chem., 267, 10935, 10.1016/S0021-9258(19)49854-2
Larsson, 1976, Pancreatic polypeptide—a postulated new hormone, Diabetologia, 12, 211, 10.1007/BF00422088
Leibowitz, 1991, Analysis of neuropeptide Y-induced feeding, Peptides, 12, 1251, 10.1016/0196-9781(91)90203-2
Lundberg, 1984, Neuropeptide Y (NPY) depresses the secretion of 3H-noradrenaline and the contractile response evoked by field stimulation in the rat vas deferens, Acta physiol. scand., 120, 477, 10.1111/j.1748-1716.1984.tb07410.x
Lundberg, 1982, Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function, Acta physiol. scand., 116, 477, 10.1111/j.1748-1716.1982.tb07171.x
Lundberg, 1986, Frequency- and reserpine-dependent chemical coding of sympathetic transmission: Differential release of noradrenaline and neuropeptide Y from pig spleen, Neurosci. Lett., 96, 10.1016/0304-3940(86)90020-0
Maccarrone, 1985, Differences in regional brain concentrations of neuropeptide Y in spontaneously hypertensive (SH) and Wistar-Kyoto (WKY) rats, Brain Res., 345, 165, 10.1016/0006-8993(85)90848-0
Macrae, 1988, Cardiovascular significance of neuropeptide Y in the caudal ventrolateral medulla of the rat, Brain Res., 456, 1, 10.1016/0006-8993(88)90339-3
Macrae, 1990, Specific alternations in cardiovascular function and in glucose utilization within lower brainstem nuclei following intracisternal neuro-peptide Y in the conscious rat, Brain Res., 515, 99, 10.1016/0006-8993(90)90582-V
Maisel, 1989, Elevation of plasma neuropeptide Y levels in congestive heart failure, Am. J. Physiol., 86, 43
Martin, 1989, Coronary constriction due to neuropeptide Y: alleviation with cyclooxygenase blockers, Am. J. Physiol., 257, H927
Martin, 1988, Blood pressure increases after injection of neuropeptide Y into posterior hypothalamic nucleus, Am. J. Physiol., 254, H879
McAuley, 1992, Possible location and function of neuropeptide Y receptor subtypes in the rat mesenteric arterial bed, J. Pharmac. exp. Ther., 261, 863
Modin, 1991, Evidence for two neuropeptide Y receptors mediating vasoconstriction, Eur. J. Pharmac., 203, 165, 10.1016/0014-2999(91)90711-X
Morris, 1987, Plasma neuropeptide Y concentration is increased after hemorrage in conscious rats, J. cardiovasc. Pharmac., 9, 541, 10.1097/00005344-198705000-00006
Mousli, 1990, G protein activation: a receptor-independent mode of action for cationic amphilphilic neuropeptides and venom peptides, Trends Pharmac. Sci., 11, 358, 10.1016/0165-6147(90)90179-C
Nakajima, 1987, Higher density of 125I-neuropeptide Y receptors in the area postrema of SHR, Brain Res., 417, 360, 10.1016/0006-8993(87)90464-1
Pernow, 1988, Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control, Acta physiol. scand., 133, 1
Pernow, 1986, Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man, Clin. Physiol., 6, 561, 10.1111/j.1475-097X.1986.tb00789.x
Pernow, 1986, Mechanisms underlying pre- and post-junctional effects of neuropeptide Y in sympathetic vascular control, Acta physiol. scand., 126, 239, 10.1111/j.1748-1716.1986.tb07811.x
Pernow, 1987, Vasoconstrictor effects in vivo and plasma disappearance rates of neuropeptide Y in man, Life Sci., 40, 47, 10.1016/0024-3205(87)90251-7
Pernow, 1987, Neuropeptide Y: Presence in perivascular noradrenergic neurons and vasoconstrictor effects on skeletal muscle blood vessels in experimental animals and man, Regul. Pept., 19, 313, 10.1016/0167-0115(87)90173-X
Pernow, 1988, Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle, Acta physiol. scand., 132, 43, 10.1111/j.1748-1716.1988.tb08296.x
Potter, 1985, Prolonged non-adrenergic inhibition of cardiac vagal action following sympathetic stimulation: Neuromodulation by neuropeptide Y?, Neurosci. Lett., 54, 117, 10.1016/S0304-3940(85)80065-3
Potter, 1991, [Pro34]Neuropeptide Y selectively identifies postjunctional-mediated actions of neuropeptide Y in vivo in rats and dogs, Eur. J. Pharmac., 193, 15, 10.1016/0014-2999(91)90194-U
Rand, 1987, Modulation of neuroeffector transmission, J. cardiovasc. Pharmac., 10, 533
Reis, 1984, Role of adrenaline neurons of ventrolateral medulla (the C1 group) in the tonic and phasic control of arterial pressure, Clin. exp. Hypertension, A6, 221, 10.3109/10641968409062562
Reis, 1988, The brain and hypertension, Arch. Neurol., 45, 180, 10.1001/archneur.1988.00520260066022
Ross, 1985, Projections from the nucleus tractus solitarii to the rostral ventrolateral medulla, J. comp. Neurol., 242, 511, 10.1002/cne.902420405
Rudehill, 1987, Release of neuropeptide Y upon hemorragic hypovolemia in relation to vasoconstrictor effects in the pig, Acta physiol. scand., 131, 517, 10.1111/j.1748-1716.1987.tb08271.x
Schwartz, 1987, Receptors on pheocromocytoma cells for two members of the PP-fold family—NPY and PP, FEBS Lett., 225, 209, 10.1016/0014-5793(87)81159-6
Schwartz, 1990, Signal epitopes in the three-dimensional structure of NPY interaction with Y1, Y2 and PP receptors, Ann. N. Y. Acad. Sci., 611, 35, 10.1111/j.1749-6632.1990.tb48920.x
Schwartz, 1990, Signal epitopes of PP-fold peptides and their precursors, 179
Shen, 1991, C-terminal neuropeptide Y fragments are mast cell-dependent vasopressor agents, Eur. J. Pharmac., 204, 249, 10.1016/0014-2999(91)90849-L
Spyer, 1981, Neuronal organization and control of the baroreceptor reflex, Rev. Physiol. Biochem. Pharmac., 88, 23, 10.1007/BFb0034536
Stanley, 1992, Evidence for neuropeptide Y mediation of eating produced by food deprivation and a variant of the Y1 receptor mediating this peptide's effect, Peptides, 13, 581, 10.1016/0196-9781(92)90093-I
Stjernquist, 1990, Further evidence for a prejunctional action of neuropeptide Y on cholinergic motor neurons in the rat uterine cervix, Acta physiol. scand., 138, 95, 10.1111/j.1748-1716.1990.tb08817.x
Sundler, 1986, Neuropeptide Y in peripheral and enteric nervous systems, A. Rev. Cytol., 102, 234
Sundler, 1989, NPY in peripheral nonadrenergic neurons, 92
Takahashi, 1988, Increases of neuropeptide Y-like immunoreactivity in plasma during insulin-induced hypoglycemia in man, Peptides, 9, 433, 10.1016/0196-9781(88)90281-1
Tatemoto, 1982, Neuropeptide Y: Complete amino acid sequence of the brain peptide, 79, 5485
Tatemoto, 1982, Neuropeptide Y—a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide, Nature, Lond., 296, 659, 10.1038/296659a0
Tseng, 1988, Cardiovascular effects of neuropeptide Y in rat brainstem nuclei, Circulation Res., 64, 55, 10.1161/01.RES.64.1.55
Tsuda, 1990, Norepinephrine release and neuropeptide Y in medullalla oblongata of spontaneously hypoertensive rats, Hypertension, 15, 784, 10.1161/01.HYP.15.6.784
Uddman, 1985, Neuropeptide Y immunoreactivity in peripheral vascular nerve fibers of the guinea pig, Regul. Pept., 10, 243, 10.1016/0167-0115(85)90019-9
Wahlestedt, 1985, Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action, J. Pharmac. exp. Ther., 234, 735
Wahlestedt, 1986, Evidence for different pre- and postjunctional receptors for neuropeptide Y and related peptides, Regul. Pept., 13, 307, 10.1016/0167-0115(86)90048-0
Wahlestedt, 1987, Effects of neuropeptide Y at sympathetic neuroeffector junctions: existence of Y1- and Y2-receptors, 231
Wahlestedt, 1990, Neuropeptide Y receptor subtypes, Y1 and Y2, Ann. N.Y. Acad. Sci., 611, 7, 10.1111/j.1749-6632.1990.tb48918.x
Wahlestedt, 1990, Norepinephrine and neuropeptide Y: vasoconstrictor cooperation in vivo and in vitro, Am. J. Physiol., 258, R736
Wahlestedt, 1992, Identification of cultured cells selectively expressing Y1-, Y2- or Y3-type receptors for neuropeptide Y/peptide YY, Life Sci., 50, PL7, 10.1016/0024-3205(92)90342-M
Wahlestedt, 1993, Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides, Science, 259, 528, 10.1126/science.8380941
Westfall, 1990, In vitro effects of neuropeptide Y at the vascular neuroeffector junction, N.Y. Acad. Sci., 611, 145, 10.1111/j.1749-6632.1990.tb48928.x